Overall, in a human BBB transport ex vivo assay IL-12Fc NHQ appeared to be better-retained compared to rIL-12 or IL-12Fc WT, and was bioactive in patient-derived GBM TME, leading to inflammatory polarization independent of influx of peripheral lymphocytes. The gene discussed is SPRR2A; the disease is glioblastoma.